In vitro performance of hemodialysis membranes after repeated processing.
BACKGROUND
Dialyzers reprocessed with chlorine-based solutions have been associated with increases in ultrafiltration coefficient and middle-molecule removal. Increased pore size has been hypothesized as the mechanism for the latter phenomenon. Dialyzers exposed to Amukin-D (Amuchina Int Inc, Gaithersburg, MD), a chlorine-based reprocessing agent, were evaluated for changes in molecular weight (MW) cutoff and ultrafiltration properties.


METHODS
In vitro MW cutoff studies were performed on Fresenius F-80A (Fresenius, Lexington, MA) and Gambro Polyflux 17 (Gambro, Lakewood, CO) hemodialyzers that were reprocessed 20 times using Amukin-D. Permeability (Uf-A), defined as the area from the ultrafiltered compartment (Uf) compared with the area from the equivalent arterial compartment (A), for dextran across the hemodialyzer membrane was determined after the initial use and after reuses 1, 5, 10, 15, and 20 by using size-exclusion chromatography.


RESULTS
Uf-A for dextran increased approximately 10-fold between hemodialyzer reuses 1 and 5. Thereafter, additional reprocessing did not increase the Uf-A ratio further. MW cutoff increased during these 5 washes and did not change thereafter.


CONCLUSIONS
Reprocessing with Amukin-D increased the MW cutoff and permeability of both hemodialyzers between reuses 1 and 5, resulting in a greater ultrafiltration rate and greater middle-molecule removal. After reuse 5, there were no further increases in MW cutoff with additional reprocessing in either hemodialyzer. This suggests that reprocessing and storage of each hemodialyzer with Amukin-D affects the permeability of dextran in a nonlinear fashion and to a finite level, such that subsequent reprocessing has no further effect on the MW cutoff of the membrane.
Johnson
Adam
A
George Washington University, School of Medicine, Washington, DC, USA.
Mishkin
Gary J
GJ
Lew
Susie Q
SQ
Mishkin
Mark
M
Abramson
Fred
F
Lecchi
Paolo
P
D000583:Amikacin / Q000494:pharmacology*; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002850:Chromatography, Gel; D003911:Dextrans / Q000493:pharmacokinetics; D017743:Equipment Reuse / Q000706:statistics & numerical data; D006801:Humans; D008567:Membranes, Artificial; D008970:Molecular Weight; D010316:Particle Size; D010539:Permeability; D011073:Polyamines; D011108:Polymers; D006435:Renal Dialysis / Q000295:instrumentation*; D013242:Sterilization / Q000379:methods*; D013450:Sulfones; D014462:Ultrafiltration
D000900:Anti-Bacterial Agents; D003911:Dextrans; D008567:Membranes, Artificial; D011073:Polyamines; D011108:Polymers; D013450:Sulfones; C017662:polysulfone P 1700; D000583:Amikacin